Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer

Código QR

Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer

Guardado en:

Detalles Bibliográficos
Autor principal:	Sreenivasa R. Chinni
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/fc394dd1fd48489c815c2812da21a3d0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.
por: Rute B Marques, et al.
Publicado: (2010)

Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
por: Rute B Marques, et al.
Publicado: (2011)

The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
por: Weina Li, et al.
Publicado: (2021)

Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
por: James J. Hoy, et al.
Publicado: (2017)

Is exercise effective in attenuating side effects of androgen deprivation therapy among prostate cancer patients?
por: Chidiebere Emmanuel Okechukwu
Publicado: (2021)

SHH-N non-canonically sustains androgen receptor activity in androgen-independent prostate cancer cells
por: Diana Trnski, et al.
Publicado: (2021)

ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development
por: Taduru L. Sreenath, et al.
Publicado: (2017)

Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
por: Emma Hörnberg, et al.
Publicado: (2011)

Castration-resistant prostate cancer: potential targets and therapies
por: Parray A, et al.
Publicado: (2012)

Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.
por: Anna Tesei, et al.
Publicado: (2013)

Changes in resting-state measures of prostate cancer patients exposed to androgen deprivation therapy
por: Julio Plata-Bello, et al.
Publicado: (2021)

Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
por: Richard Shore, et al.
Publicado: (2021)

Genome-wide analysis of androgen receptor targets reveals COUP-TF1 as a novel player in human prostate cancer.
por: Ruth Perets, et al.
Publicado: (2012)

Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
por: Dominick G A Burton, et al.
Publicado: (2013)

Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model
por: C Mirjolet, et al.
Publicado: (2017)

Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer.
por: Wenjuan Mo, et al.
Publicado: (2013)

A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer.
por: Anaïs Fradet, et al.
Publicado: (2013)

Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1
por: Zhang Y, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Aasems Jacob, et al.
Publicado: (2021)

Efficacy and Prognostic Factors of Androgen Deprivation Therapy Combined with Radiation Therapy for Prostate Cancer
por: Siping Zeng, et al.
Publicado: (2021)

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.
por: Rolf Gedeborg, et al.
Publicado: (2021)

Androgen-deprivation therapy and the risk of newly developed fractures in patients with prostate cancer: a nationwide cohort study in Korea
por: Do Kyung Kim, et al.
Publicado: (2021)

Androgen receptor-binding sites are highly mutated in prostate cancer
por: Tunç Morova, et al.
Publicado: (2020)

Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy
por: Amin Zargar, et al.
Publicado: (2019)

Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells.
por: Abhilash Samykutty, et al.
Publicado: (2013)

Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
por: Manjul Rana, et al.
Publicado: (2021)

Metabolic changes in patients with prostate cancer with androgen deprivation therapy
por: Maxim N. Peshkov, et al.
Publicado: (2020)

Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies.
por: Jinsheng Zhao, et al.
Publicado: (2014)

Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer
por: Govindi J. Samaranayake, et al.
Publicado: (2017)

Discovery proteomics defines androgen-regulated glycoprotein networks in prostate cancer cells, as well as putative biomarkers of prostatic diseases
por: Jordy J. Hsiao, et al.
Publicado: (2021)

Lipid-coated gold nanocomposites for enhanced cancer therapy
por: Kang JH, et al.
Publicado: (2015)

Mir-15A Reconstitution in Prostate Cancer Cell Line Suppresses Cancer Progression Through Down Regulation of MYB and Androgen Receptor Upregulation
por: Todorova K., et al.
Publicado: (2015)

Author Correction: Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
por: Manjul Rana, et al.
Publicado: (2021)

Androgen-induced cell migration: role of androgen receptor/filamin A association.
por: Gabriella Castoria, et al.
Publicado: (2011)

Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
por: Philippe O Gannon, et al.
Publicado: (2010)

Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion
por: Bianca Cioni, et al.
Publicado: (2020)

Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients
por: Divya Bhagirath, et al.
Publicado: (2021)

Embedding supervised exercise training for men on androgen deprivation therapy into standard prostate cancer care: a feasibility and acceptability study (the STAMINA trial)
por: Sophie Reale, et al.
Publicado: (2021)

Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.
por: Jae-Uk Jeong, et al.
Publicado: (2021)

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer
por: Christine Henzler, et al.
Publicado: (2016)